Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its ...

Term sheet contemplates preparation of definitive documentation pursuant to which TerraPower would provide funding for the <a target=_blank href= ...

As of September 30, 2024, ARI recorded $159.7 million in other assets on its condensed consolidated balance sheet consisting of an equity method interest in the joint venture with other Apollo-managed ...

Q3 2024 net income was $16 million, or $1.87 per diluted share, versus $24 million, or $2.71 per diluted share, in the prior ...

Teyana Taylor is a star on the rise concerning her influence on fashion. Naturally, she attended the CFDA Awards in a ...

Get your space ready for the holidays with these discountsBy Samantha B. GordonWith Black Friday just one month away, you can ...

Nomlabofusp program update expected mid-December to include available safety, pharmacokinetic (PK) and frataxin data, as well as available ...

Standard BioTools will host a conference call and webcast on October 30, 2024 at 1:30 p.m. PT (4:30 p.m. ET) to discuss third ...

Q3 2024 Earnings Call Transcript October 30, 2024 8:30 AM ETCompany ParticipantsStephen Amato - Senior Director of ...

Clarus' future value lies in how effectively management can revamp the Black Diamond Equipment label and scale the Adventure ...

First patient dosed in Phase 2 clinical trial with NGC-Cap for metastatic breast cancer Positive data from preclinical studies support NGC-Iri’s ...

$ 32.74-0.14-0.43% ...